Back to the main directory
Press Release
- Cannabix Technologies Receives Notice of Allowance from USPTO for Contactless Breath Analysis by GlobeNewsWire
- AIM ImmunoTech Resumes Trading on NYSE American by GlobeNewsWire
- H2O America’s General Counsel, Willie Brown, Appointed to CalChamber Board of Directors by GlobeNewsWire
- Varonis Announces Integration With ChatGPT Enterprise by GlobeNewsWire
- Fortinet Strengthens Code-to-Cloud Security with CNAPP Enhancements and Launches Expanded Solution Availability in AWS Marketplace by GlobeNewsWire
- Nutanix Study Finds Public Sector Embraces Generative AI, but Faces Security, Skills, and Infrastructure Gaps by GlobeNewsWire
- Arteris Accelerates AI-Driven Silicon Innovation with Expanded Multi-Die Solution by GlobeNewsWire
- LogicMark, Inc. Appoints Jeffrey Durkin as Senior Vice President of Sales to Drive Strategic Growth in the Care Economy and Personal Safety Markets by GlobeNewsWire
- Angi Launches New “AI Helper” as it Celebrates 30 Years of Innovation by GlobeNewsWire
- ibex Crowns the Winners of the 4th Annual CX Leadership Awards at CCW Las Vegas by GlobeNewsWire
- AirJoule Technologies Announces Memorandum of Understanding with Data Center Developer to Advance Onsite Water Production Using Waste Heat by GlobeNewsWire
- Upexi’s Chief Strategy Officer to Present at The ICR Conference Spotlight Series on June 20th by GlobeNewsWire
- AvePoint Launches New Advanced Security and Optimization Features to Elements Platform by GlobeNewsWire
- Processa Pharmaceuticals Signs Binding Term Sheet Granting Intact Therapeutics Exclusive Option to License Phase 2 Gastroparesis Drug Candidate by GlobeNewsWire
- Mercurity Fintech Partners with Franklin Templeton to Advance Real-World Asset Tokenization with BENJI Tokens and FOBXX Fund by GlobeNewsWire
- Ernst & Young LLP (EY US) Announces Jason Matuszewski, CEO of BioStem Technologies, as an Entrepreneur Of The Year® 2025 Florida Award Winner by GlobeNewsWire
- Thiogenesis Announces Second Site Begins Enrolling in Phase 2 MELAS Clinical Trial and Provides Update by Newsfile Corp.
- Northstrive Biosciences Announces Initiation of Phase II of Collaboration to Develop AI Powered Therapies for Obesity and Cardiometabolic Diseases by GlobeNewsWire
- Thérapeutique Knight annonce la clôture de l'acquisition précédemment annoncée de Paladin by GlobeNewsWire
- Danske Bank A/S, transactions by persons discharging managerial responsibilities by GlobeNewsWire
- SEALSQ Invests $10 Million in WISeSat.Space, at $115 Million Pre-Money Valuation, to Accelerate Planned Satellite Constellation Deployment, Space-Based Quantum Key Distribution (QKD) Communications, and Decentralized IoT Transactions by GlobeNewsWire
- Middlefield Canadian Income PCC: Net Asset Value(s) by GlobeNewsWire
- TEN, Ltd. Reports Profits for First Quarter 2025 and Declares First Semi-Annual Common Share Dividend of $0.60 by GlobeNewsWire
- Form 8.3 - Empiric Student Property Plc by GlobeNewsWire
- Form 8.3 - Primary Health Properties Plc by GlobeNewsWire